Primary Parkinsonian Pain Diagnostic Questionnaire: Development and Validation of This Questionnaire (3PDQ)

Toulouse University Hospital

Status

Completed

Conditions

Parkinson Disease

Treatments

Diagnostic Test: Self-questionnaire 3PDQ

Study type

Interventional

Funder types

Other

Identifiers

NCT03940872

RC 31/18/0034

Details and patient eligibility

About

Development and validation of a diagnosis questionnaire of parkinsonian primary pain: the "Primary Parkinsonian Pain Diagnostic Questionnaire" (3PDQ)

Full description

The aim of this study is to develop and validate a French self-questionnaire to diagnose parkinsonian primary : the "Primary Parkinsonian Pain Diagnostic Questionnaire" (3PDQ). It will allow clinicians to distinguish this pain from the other pain of the parkinsonian patient (whether or not related to Parkinson's disease).

The development and validation of the 3PDQ self-questionnaire will take place in 3 sequential steps:

design of the self-questionnaire
appearance validity study
validation of the self-questionnaire

Participants :

Appearance validity study: 40 painful parkinsonian patients Validation study: 200 painful parkinsonian patients (10 patients per item)

Duration of the study :

Duration of the inclusion period:

Appearance validity study : 6 months
Validity study : 20 months

Duration of participation for each patient:

Appearance validity study : about 30 min
Validity study : 3 days maximum Total duration of the study: (with results analysis): 3 years

Enrollment

227 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with Parkinson Disease (PD)
Patients who have chronic pain (for at least 3months) moderate to severe (intensity ≥ 4/10 on visual analogue scale from 0 to 10) specific or unspecific to PD
Patients who have one type of pain or different type of pain: in this case, patients should suffered from one predominant pain and be able to identify it
Patients who have stable analgesic medication during the study
Patients who understand and speak fluently French
Patients with health insurance
Patients who signed the written informed consent form

Exclusion criteria

Patients with severe depression according to Diagnostic and Statistical Manual (DSM) V criteria
Analgesic medication modified recently (less than 1month)
Patients with psycho-actives substances or alcohol abused
Patients with cognitive impairment (MoCA score < 25)